title: [Cerebral infarction after ovarian hyperstimulation in the era of thrombolysis].
abstract: Ischemic stroke is a very rare complication but classic ovarian hyperstimulation. We report the cases of three young women aged 35, 37 and 27 years. All three were victims of ischemic formed by proximal occlusion of the middle cerebral artery secondary to ovarian hyperstimulation. The first and the third had a proximal occlusion of the right middle cerebral artery occlusion and the second of the left middle cerebral artery. The last two have benefited from a patient intravenous thrombolysis. The first patient did not receive thrombolysis because it was out of time. Against by their evolution was different. The first has almost recovered its deficit, the second sequelae quite heavy after craniectomy and the third died despite her craniectomy.
authors.affiliation: Service de neurologie, CHU de Tokoin, BP 57, Lomé, Togo; Unité 201, hôpital neurologique, 59, boulevard Pinel, 69677 Bron, France. Electronic address: vincent_kumako@yahoo.fr.
authors.forename: V
authors.initials: V
authors.lastname: Kumako
authors.affiliation: Unité 201, hôpital neurologique, 59, boulevard Pinel, 69677 Bron, France.
authors.forename: L
authors.initials: L
authors.lastname: Derex
authors.affiliation: Service de neurologie, centre hospitalier, 179, boulevard Maréchal-Juin, 26953 Valence cedex 9, France.
authors.forename: K
authors.initials: K
authors.lastname: Blanc-Lasserre
authors.affiliation: Service de neurologie, centre hospitalier, 179, boulevard Maréchal-Juin, 26953 Valence cedex 9, France.
authors.forename: A
authors.initials: A
authors.lastname: Beschet
authors.affiliation: Service de neurologie, centre hospitalier, 179, boulevard Maréchal-Juin, 26953 Valence cedex 9, France.
authors.forename: H
authors.initials: H
authors.lastname: Benhamouda
authors.affiliation: Unité 201, hôpital neurologique, 59, boulevard Pinel, 69677 Bron, France.
authors.forename: N
authors.initials: N
authors.lastname: Nighoghossian
mesh_terms: D000328:Adult; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D003399:Craniotomy; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D019586:Intracranial Hypertension / Q000209:etiology; D008279:Magnetic Resonance Imaging; D016471:Ovarian Hyperstimulation Syndrome / Q000150:complications*; D010062:Ovulation Induction / Q000009:adverse effects*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D001241:Aspirin
keywords: Fécondation in vitro; Hyperstimulation ovarienne; In vitro fertilization; Infarctus cérébraux; Ovarian hyperstimulation; Stroke; Thrombolyse; Thrombolysis